Type
. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues. International journal of antimicrobial agents. 2003;21(3):251-5.
Type
Leprosy elimination campaigns: impact on case detection. Weekly epidemiological record [Internet]. 2003;78(3):9-16. Available from: http://www.who.int/wer/2003/en/wer7803.pdf
Type
. Follicular mucinosis in suspected leprosy. Indian journal of leprosy. 2002;74(4):341-7.
Type
. An interventional strategy to strengthen integration of NLEP into primary health care. Indian journal of leprosy. 2002;74(4):335-40.
Type
. Grip and pinch strength in relation to function in denervated hands. Indian journal of leprosy. 2002;74(4):319-28.
Type
. Multidrug therapy in leprosy can prevent relapse--a retrospective study. Indian journal of leprosy. 2002;74(4):313-8.
Type
. Building national medicine: leprosy and power in Colombia, 1870-1910. Social history of medicine : the journal of the Society for the Social History of Medicine. 2002;15(1):89-108.
Type
. [Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia]. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2002;35(5):453-60. Available from: http://www.scielo.br/pdf/rsbmt/v35n5/13162.pdf
Type
. [Systematic search for parasites among leprosy patients in Mali]. Medecine tropicale : revue du Corps de sante colonial. 2002;62(5):503-6.
Type
. [The Mycobacterium leprae genome: from sequence analysis to therapeutic implications]. Medecine tropicale : revue du Corps de sante colonial. 2002;62(5):473-9.